EGFR and neoplasm: Another work in which the authors develop an in vivo tumor model of human oral squamous carcinoma using xenografts reports that gefitinib treatment inhibits EGFR endocytosis [64], suggesting that receptor kinase activity is required for receptor internalization [65].